AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-10933623/diabetes-drug-warner-lambert.html" title="Facts and information about Diabetes drug. (Warner-Lambert Co. licenses new diabetes drug from Sankyo)(RX: Mass Market Retail Pharmacy)">Diabetes drug. (Warner-Lambert Co. licenses new diabetes drug from Sankyo)(RX: Mass Market Retail Pharmacy)</a>

Close Set up an RSS feed that alerts you when new articles from Chain Drug Review are available.

Frequently asked questions about RSS feeds

Diabetes drug. (Warner-Lambert Co. licenses new diabetes drug from Sankyo)(RX: Mass Market Retail Pharmacy)

Chain Drug Review

| June 17, 1991 | COPYRIGHT 2009 Racher Press, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Diabetes Drug

NEW YORK - Warner-Lambert Co. has licensed a new diabetes drug from Sankyo, a Japanese pharmaceutical firm, for the treatment of Type II, or noninsulin-dependent diabetes patients, who account for about 40% of all diagnosed cases.

According to Warner-Lambert spokesmen, the drug (CI-991)…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


New Diabetes Drug by University of Utah.: Press release article from: M2 Presswire March 28, 2007 700+ words
M2 PRESSWIRE-28 March 2007-RNCOS: New Diabetes Drug by University of Utah(C)1994-2007 M2 COMMUNICATIONS...market research report provides an insight into the global diabetes drug market. It highlights the worldwide trends in insulin...


Ajinomoto gives Sankyo rights to make, sell new diabetes drug.: Newspaper article from: Kyodo News International (Tokyo, Japan) August 31, 2006 700+ words
...exclusive global rights to develop, make and sell its new diabetes drug, AJD101, and related compounds. According to the...due to changes in lifestyle habits, expanding the diabetes drug market, Ajinomoto added. To see more of Kyodo News...


New diabetes drug.: News wire article from: Chemical Business Newsbase June 26, 2006 700+ words
(From Chemical Business NewsBase - Chemical Business (India)) Arxxant, a new diabetes drug developed by Eli Lilly, can reduce the risk of vision loss in diabetes patients based on a three-year study. According to results...


New diabetes drug holds promise of ending weight gain, hypoglycemia.(Originated...: Newspaper article from: Knight Ridder/Tribune News Service Lewis, Claude May 8, 1995 700+ words
...able to alter their daily regimes of insulin injections, special diets and boring exercise programs. The first new diabetes drug in the United States in more than 20 years has been approved by the U.S. Food and Drug Administration. It appears...


Scientist claims to have developed new diabetes drug.: News wire article from: PTI - The Press Trust of India Ltd. March 29, 2008 700+ words
Scientist claims to have developed new diabetes drug Rajkot, Mar 29 (PTI) -- A Chennai-based scientist has claimed to have developed new medicines that effectively tackle diabetes...


SEC Opens Inquiry into Amylin Pharmaceuticals Release of New Diabetes Drug.: Newspaper article from: Knight Ridder/Tribune Business News December 20, 2003 700+ words
...launched an informal inquiry into Amylin Pharmaceuticals and the San Diego company's release of news about its new diabetes drug Symlin. The company said it believes the inquiry relates to a possible violation of the agency's Regulation FD...


Ajinomoto, Sankyo in Joint Development, Manufacture and Marketing of AJD101,...: Magazine article from: JCNN News Summaries August 31, 2006 700+ words
...an agreement on August 31 which will grant Sankyo exclusive global rights to develop, manufacture and market the new diabetes drug AJD101 and related compounds currently being developed by Ajinomoto. Ajinomoto will retain the rights to manufacture...


Sankyo and Ajinomoto reach agreement on the development, manufacture and...: News wire article from: Chemical Business Newsbase August 31, 2006 700+ words
...agreement on 31 Aug 2006 which will grant Sankyo exclusive global rights to develop, manufacture and market the new diabetes drug AJD101 and related compounds currently being developed by Ajinomoto. Ajinomoto will retain the rights to manufacture...


Whitehouse Station, N.J.--shares of Merck & Co. dropped 6.5 percent to close at...: News wire article from: Drug Store News - NewsFirst November 26, 2003 700+ words
WHITEHOUSE STATION, N.J. -- Shares of Merck & Co. dropped 6.5 percent to close at $42.21 Friday after the drug maker said it was pulling the plug on the development of its new diabetes drug MK-767 because rare malignant tumors were discovered in tests on mice.


RNCOS: New Diabetes Drug by University of Utah.: News wire article from: Europe Intelligence Wire March 28, 2007 700+ words
...technologies and therapeutic compounds in drug delivery. The market research report provides an insight into the global diabetes drug market. It highlights the worldwide trends in insulin supply and demand, insulin delivery market, various diabetes treatments...

For more facts and information, see all results

Source: HighBeam Research, Diabetes drug. (Warner-Lambert Co. licenses new diabetes drug from...

The AccessMyLibrary advertising network includes: